← Open Payments lookup

ASIM GUHA ROY: Open Payments

NPI 1083659528 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$790 in 14 payments from 10 companies in 2025. Trend: 2023 $1,035 · 2024 $938 · 2025 $790

Food & beverage: $790
CompanyPaymentsAmount
UCB, Inc.3$300
Amgen Inc.1$122
Teva Pharmaceuticals USA, Inc.1$121
Otsuka America Pharmaceutical, Inc.3$70
Inspire Medical Systems, Inc.1$53
MicroTransponder, Inc.1$34
Lilly USA, LLC1$26
Corcept Therapeutics1$23
AstraZeneca Pharmaceuticals LP1$20
Esperion Therapeutics, Inc.1$20

Products named: Nayzilam, UPLIZNA, AUSTEDO XR, REXULTI, INSPIRE, Briviact, MOUNJARO, Korlym.

Industry payments across CA — which companies pay providers there.